Xeris Biopharma Holdings Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2016
Period Ending	Jan '25 Jan 23, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2016
Market Capitalization	398	255	150	270	-	-	Upgrade
Market Cap Growth	50.56%	69.77%	-44.38%	-	-	-	Upgrade
Enterprise Value	562	382	188	266	-	-	Upgrade
Last Close Price	2.70	1.87	1.01	2.19	-	-	Upgrade
PS Ratio	2.27	1.98	1.64	7.37	-	-	Upgrade
PB Ratio	-14.99	-47.86	4.00	3.84	-	-	Upgrade
EV/Sales Ratio	3.69	2.97	2.05	7.26	-	-	Upgrade
Debt / Equity Ratio	-9.57	-33.79	4.38	0.92	2.58	4.04	Upgrade
Asset Turnover	0.58	0.49	0.34	0.21	0.15	0.02	Upgrade
Inventory Turnover	0.84	0.90	1.06	1.01	1.77	-	Upgrade
Quick Ratio	1.21	1.17	2.08	1.52	4.99	2.94	Upgrade
Current Ratio	1.79	1.64	2.54	1.80	5.40	3.20	Upgrade
Return on Equity (ROE)	-	-324.20%	-134.83%	-190.28%	-378.20%	-279.56%	Upgrade
Return on Assets (ROA)	-8.70%	-8.25%	-15.50%	-28.45%	-38.01%	-66.80%	Upgrade
Return on Capital (ROIC)	-11.90%	-11.81%	-23.58%	-43.37%	-52.67%	-84.97%	Upgrade
Earnings Yield	-11.82%	-19.18%	-52.34%	-33.59%	-	-	Upgrade
FCF Yield	-6.04%	-15.18%	-57.18%	-26.44%	-	-	Upgrade
Buyback Yield / Dilution	-5.01%	-1.51%	-71.62%	-85.32%	-63.32%	-116.75%	Upgrade
Total Shareholder Return	-5.01%	-1.51%	-71.62%	-85.32%	-63.32%	-116.75%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.